U.S. Banks Stock News

In March 2026, Illumina and Labcorp expanded their precision oncology collaboration to develop and distribute next-generation sequencing-based cancer tests, including co-commercializing Labcorp's FDA-authorized PGDx elio plasma focus Dx liquid biopsy alongside Illumina's FDA-approved TruSight Oncology Comprehensive for solid tumors. This alliance aims to widen access to both tissue and liquid biopsy biomarker testing, support companion diagnostic development for drugmakers, and strengthen...

Redemption and Buyback Moves Put Capital Management in Focus Banc of California (BANC) drew investor attention after announcing plans to redeem $385 million of subordinated notes originally issued by Pacific Western Bank and to extend its share repurchase plan through March 16, 2027. See our latest analysis for Banc of California. The latest debt redemption and buyback announcements arrive after a 1-day share price return of 3.53% to US$17.58. However, the 90-day share price return of 8.86%...

If you are wondering whether Inspire Medical Systems at around US$51.58 is starting to look interesting, the key question is how its current price stacks up against its underlying worth. The share price has been under pressure, with a 0.9% decline over the last week, a 20.0% decline over the last month, and a 44.1% decline year to date, adding to a 67.4% decline over the past year and 77.2% and 75.1% declines over the past three and five years respectively. These returns have kept Inspire...

In late March 2026, Jefferies issued positive coverage on Flutter Entertainment, highlighting the FanDuel Predicts app’s strong download momentum and potential to add an estimated US$125.00 million in annual revenue that is not yet reflected in company guidance or market forecasts, even as regulatory scrutiny of prediction markets increases. An interesting angle is how UConn’s upset win over Duke underscored the way underdog victories can support sportsbook profitability, indirectly...

Wondering if Artisan Partners Asset Management at around US$36.39 is offering value right now, or if the easy money has already been made. The stock is up 1.6% over the last 7 days, although it shows a 9.7% decline over 30 days, a 12.1% decline year to date, and a 0.3% return over the past year, which may have shifted how investors see its risk and return profile. Recent coverage has focused on the stock’s mixed return picture, with a modest 0.3% 1 year return sitting alongside a 46.5%...

Mattel (MAT) is back in focus after unveiling a global Masters of the Universe product program tied to the 2026 live action film, alongside fresh layoffs at its El Segundo headquarters. See our latest analysis for Mattel. Despite the Masters of the Universe launch and ongoing restructuring, Mattel’s 30 day share price return decline of 14.28% and year to date share price return decline of 27.5% sit alongside a 1 year total shareholder return decline of 25.22%, pointing to fading momentum...

Astera Labs (ALAB) has drawn fresh attention after being added to the FTSE All-World Index and filing a new shelf registration. This filing gives the company flexibility to issue up to US$704.8 million in common stock. See our latest analysis for Astera Labs. Astera Labs’ recent FTSE All-World Index inclusion and shelf registration come after a mixed price pattern, with a 9.30% 1 day share price return contrasting with weaker 30 day and year to date share price returns, while the 1 year total...

Comfort Systems USA, Inc. (NYSE: FIX) was added to the FTSE All-World Index (USD) on 21 March 2026, further cementing its position among globally tracked construction and building-services companies. This index inclusion coincides with growing attention on the company’s upcoming fiscal Q1 2026 earnings, where analysts are looking for double-digit earnings growth and continued backlog strength. We’ll now examine how the FTSE All-World Index inclusion could influence Comfort Systems USA’s...

Abercrombie & Fitch (ANF) is drawing attention after operational improvements, including average comparable store sales growth of 10% over the past two years, a reported 62.8% gross margin and very large earnings per share growth supported by share repurchases. See our latest analysis for Abercrombie & Fitch. The recent 1-day share price return of 4.79% takes Abercrombie & Fitch to US$91.37. However, this sits against a 90-day share price return of negative 27.41% and a 1-year total...

In March 2026, Hims & Hers Health announced a collaboration with Novo Nordisk to offer eligible customers a broad range of FDA-approved GLP-1 medications, including the Wegovy pill, alongside a new weight loss membership featuring 24/7 provider access and personalized support starting at US$39 for the first month and US$149 thereafter. This partnership expands Hims & Hers’ presence in the fast-growing medical weight management category by pairing branded GLP-1 therapies with a...

This article walks through key numbers to help you judge whether Moody's current share price lines up with its underlying worth and if the stock looks expensive, cheap or somewhere in between. Moody's last closed at US$436.25, with returns of 1.8% over 7 days, an 8.7% decline over 30 days, a 12.6% decline year to date and a 6.2% decline over the last year. The 3 year and 5 year returns stand at 47.1% and 47.0% respectively. Recent coverage has focused on how Moody's performance over 3 and 5...

Intel stock in focus Intel (INTC) is back in focus for investors after recent share price moves and fresh attention on its foundry and data center businesses, prompting a closer look at its current fundamentals and valuation. See our latest analysis for Intel. At a share price of US$44.13, Intel has seen a sharp 7.1% 1 day share price return, a 19.6% 90 day share price return, and a very large 1 year total shareholder return. This suggests momentum has recently strengthened after a softer 1...

MongoDB, Inc. recently announced that outgoing Chief Revenue Officer Paul Capombassis will support a leadership transition through the second quarter of 2026, as Ryan Mac Ban, formerly CRO at Confluent, steps into the Chief Revenue Officer role effective April 27, 2026 to lead the global sales organization. This hire brings two decades of enterprise software sales experience into MongoDB’s go-to-market leadership at a time when the company is emphasizing its next phase of growth and...

POET Technologies reported in the past that it had shifted from development to execution by securing more than US$225,000,000 in financing in 2025, adding a further US$150,000,000 in January 2026, and landing a production order above US$5,000,000 for its POET Infinity optical engines. This combination of large-scale funding and an initial multi-million-dollar production order highlights how POET is positioning its optical engine platform for commercial-scale manufacturing and customer...

Rezolve AI (RZLV) has just put fresh FY 2025 numbers on the table, with second half revenue of about US$40.5 million and a basic EPS loss of US$0.14, backed by trailing twelve month revenue of roughly US$46.8 million and a basic EPS loss of US$0.38. The company has seen revenue move from just US$0.1 million in the second half of FY 2024 to US$6.3 million in the first half of FY 2025 and then to US$40.5 million in the latest half, while basic EPS losses shifted from US$0.98 to US$0.25 and then...

If you are wondering whether Buckle at around US$50.36 offers solid value or is pricing in too much optimism, this breakdown will help you frame that question clearly. The stock has had a mixed short term patch, with a 0.6% return over the last week, a 6.0% decline over the past month, and a 6.5% decline year to date, as well as a 42.9% return over the last year and 84.3% and 112.4% returns over the past 3 and 5 years. Recent coverage has focused on Buckle in the context of broader retail...

Wondering if Cardinal Health at around US$211 a share still offers value, or if most of the opportunity is already reflected in the price. The stock has returned 2.0% over the last week, seen a 7.8% decline over the last 30 days, yet is up 2.7% year to date and 55.8% over the past year, with very large gains over 3 and 5 years. Recent headlines have focused on Cardinal Health's broader role as a major healthcare distributor and solutions provider, which keeps attention on how its scale and...

Joby Aviation (NYSE:JOBY) completed a test flight with its first conforming aircraft. The flight is a key step ahead of the company’s upcoming FAA Type Inspection Authorization certification. This milestone marks progress toward regulatory approval for future commercial operations. Joby Aviation, listed on the NYSE under the ticker JOBY, focuses on electric vertical take off and landing aircraft intended for short haul passenger trips. The recent test flight with a conforming aircraft comes...

Baidu recently highlighted its evolution from a traditional search provider into an AI-centered technology platform, anchored by its ERNIE foundation model and Baidu Cloud, which now support a broad suite of multimodal AI applications for Chinese enterprises. A particularly distinctive development is Baidu’s use of Digital Human technology to automate marketing, sales, and customer engagement, signaling a push toward AI-native business operations across its ecosystem. We’ll now examine how...

In March 2026, Safe Harbor Marinas announced an exclusive partnership naming Chubb as the preferred insurance provider for members across more than 150 marinas, giving them access to Chubb’s Masterpiece Select Recreational Marine Insurance with wide-ranging coverage features. This deal highlights how Chubb is using specialized products, such as high-end recreational marine policies, to deepen reach in niche insurance segments with targeted customer bases. We’ll now examine how this...

GlobalFoundries has filed multiple U.S. lawsuits accusing Tower Semiconductor (TSEM) of infringing 11 patents related to high performance chip manufacturing processes, and is seeking to block the importation and sales of certain Tower products. See our latest analysis for Tower Semiconductor. The legal action has arrived after a strong run, with a 1 month share price return of 40.53% and a 1 year total shareholder return of more than 4x. However, the 7 day share price return of 2.95% suggests...

M/I Homes (MHO) has been drawing attention after recent share price swings, with the stock up about 3.2% on the day but showing a 13.9% decline over the past month. See our latest analysis for M/I Homes. That 3.2% 1 day share price gain comes after a 13.9% 30 day share price decline and a mildly negative year to date share price return. However, the 3 year total shareholder return near 100% and 5 year total shareholder return near 96% highlight how longer term holders have still seen strong...

Revolution Medicines recently reported early clinical data showing that its RAS-targeting candidates daraxonrasib and zoldonrasib exhibited activity in second-line metastatic pancreatic cancer, an area with few effective treatments. This progress in directly targeting RAS(ON) via a molecular glue mechanism highlights a differentiated scientific approach in a difficult-to-treat tumor type. Next, we will examine how this early pancreatic cancer data, particularly the molecular glue RAS(ON)...

What recent performance says about Lyft (LYFT) Recent trading in Lyft (LYFT) has been choppy, with the share price up about 5.1% over the past day and 1.1% over the past week, but showing weaker returns over the past month and past 3 months. Over longer periods the picture is mixed, with a roughly 8.7% total return over the past year and a much stronger multiyear total return, while year to date performance and the past 5 years reflect sizeable drawdowns from earlier levels. See our latest...